Trial Profile
Comparison of Operating Conditions, Postoperative Recovery and Overall Satisfaction Between Deep and Restricted Neuromuscular Blockade for Spinal Surgery Under General Anesthesia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 May 2022
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary) ; Rocuronium bromide
- Indications Neuromuscular blockade
- Focus Pharmacodynamics
- 27 Mar 2017 Status changed from recruiting to completed.
- 10 Jul 2016 Planned primary completion date changed from 1 Oct 2016 to 1 Dec 2016.
- 10 Jul 2016 Status changed from not yet recruiting to recruiting.